This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.
Rigante, D., Cipolla, C., Rossodivita, A. N., Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease, <<CLINICAL PEDIATRIC ENDOCRINOLOGY>>, 2018; 2018 (27(2)): 101-105. [doi:10.1297/cpe.27.101] [http://hdl.handle.net/10807/118955]
Recombinant human growth hormone in neonatal-onset multisystem inflammatory disease
Rigante, Donato
;Cipolla, Clelia;Rossodivita, Aurora Natalia
2018
Abstract
This report indicates that stunted growth as part of the neonatal-onset multisystem inflammatory disease (NOMID) clinical scenery can be related to the skeletal picture of the disease itself, but also to growth hormone deficiency and that a substantial response to recombinant human growth hormone can be observed in NOMID.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
